Marta G. Podda
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Hypertension in Wilms Tumor at Diagnosis: Proposed Treatment Recommendations Starting From a Bi-Institutional Retrospective Observational Study.
Journal: Pediatric blood & cancer
Published: May 15, 2026
The VIVA Regimen (Vinorelbine, Ifosfamide, Vincristine, and Actinomycin-D) for High-Risk Rhabdomyosarcoma: Feasibility and Outcomes From a Single-Institution Study.
Journal: Pediatric blood & cancer
Published: April 07, 2026
Forceful survivorship: The desire to procreate in parents of cancer patients.
Journal: Tumori
Published: February 09, 2026
Who leads, who treats, what dose? European paediatric differentiated thyroid carcinoma practice-an European Cooperative Study Group for Paediatric Rare Tumours survey.
Journal: European journal of endocrinology
Published: February 07, 2026
Bereavement in paediatric oncology: programme evaluation.
Journal: BMJ supportive & palliative care
Published: January 20, 2026
Long-term adverse effects of modern Wilms tumour therapies: implications for monitoring.
Journal: Nature reviews. Urology
Published: January 09, 2026
Advancing Neuroblastoma Surgery through the Clinical Integration of Virtual Reality and Indocyanine Green Fluorescence-Guided Imaging: A Case Report.
Journal: European journal of pediatric surgery reports
Published: May 03, 2025
Malignant Peripheral Nerve Sheath Tumor in Children and Adolescents: Local Treatment in a Retrospective Single-Center Experience.
Journal: Pediatric blood & cancer
Published: March 31, 2025
Pediatric Craniofacial Osteosarcoma: The Milano Experience.
Journal: Pediatric blood & cancer
Published: January 13, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial.
Journal: Pediatric blood & cancer
Published: October 04, 2024
Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype.
Journal: Neuro-oncology
Published: September 27, 2024
Last Updated: 09/26/2026